Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

New treatments for obesity and other metabolic disorders disclosed

June 13, 2005

New therapeutics for cancer disclosed in recent patents

June 13, 2005

Novel antiinflammatory/analgesic agents claimed by Bayer

June 10, 2005

Arginine-vasopressin V1b receptor antagonists emerge from Taisho R&D

June 10, 2005

Recent Icos patents cover novel treatments for fibrotic disorders

June 10, 2005

New agents for asthma and other respiratory diseases reported in recent patent literature

June 9, 2005

Recent patents describe new antiinfective agents

June 9, 2005

New treatments for diabetes reported in recent patent literature

June 8, 2005

Recent Bayer patent describes new antiretroviral agents

June 8, 2005

Merck & Co. patents cover novel NR2B receptor antagonists

June 8, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...